Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-09-16
1996-02-27
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514428, 546233, 548572, A61K 31445, C07D21132
Patent
active
054949211
ABSTRACT:
Fibrinogen receptor antagonists having the formula ##STR1## for example ##STR2##
REFERENCES:
patent: 5227490 (1993-07-01), Hartman et al.
patent: 5264420 (1993-11-01), Duggan et al.
patent: 5272158 (1993-12-01), Hartman et al.
patent: 5281585 (1994-01-01), Duggan et al.
patent: 5292756 (1994-03-01), Duggan et al.
patent: 5294616 (1994-03-01), Duggan et al.
patent: 5321034 (1994-06-01), Duggan et al.
patent: 5334596 (1994-08-01), Hartman et al.
patent: 5340798 (1994-08-01), Nutt et al.
patent: 5344957 (1994-09-01), Bovy
Birchenough Laura A.
Egbertson Melissa S.
Hartman George D.
Huang Evelyn
Ivy C. Warren
Merck & Co. , Inc.
Parr Richard S.
Winokur Melvin
LandOfFree
Fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1679557